Sterilization products company STERIS (NYSE:STE) is looking to hire more than 50 employees at its suburban Cleveland headquarters, with a particular emphasis on engineers. The healthcare jobs hiring binge is part of the company’s plan to add about 300 positions to its Mentor, Ohio headquarters in the coming years. The hires are related to the […]
The top executive with sterilization products maker STERIS (NYSE:STE) said the transition to a replacement version of its flagship sterilization device is “moving along as expected.” The Mentor, Ohio-based company during the most recent quarter shipped 700 units of its new System 1E device, which is a liquid chemical sterilizing system used by hospitals, surgical […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The U.S. Food and Drug Administration has given STERIS (NYSE: STE) customers an additional six months to transition from the company’s recalled System 1 sterilization device. Customers have been given until Feb. 2 to make the change to an alternate processing system, according to a regulatory filing from Mentor, Ohio-based STERIS. The company said it […]
Sterilization and decontamination technology firm STERIS (NYSE: STE) says construction on a new $11 million, 55,000-square-foot customer solutions center in suburban Cleveland is expected to wrap up in May.
Decontamination technologies maker Steris Corp.'s (NYSE:STE) struggles with the FDA continue, as the federal agency sent the medical device company a warning letter for making improper marketing claims about several steam-sterilization devices.
Infection prevention and decontamination technologies maker Steris Corp.'s (NYSE:STE) third-quarter profits dropped 20 percent as the company struggles to replace lost revenue from its recalled System 1 sterilization device. The company also decreased its projection for full-year revenue, citing lower-than-anticipated shipments of its new System 1E sterilization device, a replacement product for System 1.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Sterilization products maker Steris Corp. (NYSE: STE) is hosting a "virtual career fair" with the hopes of hiring about 100 workers for its Mentor, Ohio, headquarters. Most positions Steris has listed appear to be in customer service, though there are also openings in plenty of other areas -- engineering, regulatory affairs, and training and development, for example.
STERIS Corp. (NYSE: STE) has begun shipping the replacement to its System 1 sterilization system, as the company looks to put one of its more difficult periods in its past. The company said shipments of its new System 1E wouldn't have a material effect on third-quarter financial results, but the shipments are an important step for STERIS, which has spent the last year trying to work its way back from a federal safety alert that said its System 1 device could harm patients.
Sterilization products maker STERIS Corp. (NYSE: STE) has received a warning letter from the Food and Drug Administration for quality control and record-keeping violations at a Texas plant. The Sept. 27 letter cited five violations at the company's Grand Prairie, Texas, plant, which performs bulk sterilizations of other companies' products, often medical devices.
Mal Mixon led Invacare for three decades and powered wheelchair sales as well as the company's identity. Read about five key moments in Mixon's leadership at Invacare, including his initial $10,000 investment and his innovations in motorized wheelchairs.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Infection prevention and decontamination technologies maker STERIS Corp. (NYSE:STE) has returned to quarterly profitability, a sign that an end to the struggles surrounding its flagship sterilization technology may be within sight.
Updated 12:10 p.m. Infection prevention and decontamination technologies maker STERIS Corp. (NYSE: STE) lost $45 million in its fiscal first quarter, thanks to setting aside $110 million to cover a rebate program in a bid to hold on to customers of its flagship sterilization technology. The Mentor, Ohio, company said more customers than expected may […]
STERIS Corp. (NYSE: STE) will give shareholders a say on the company’s executive compensation program at their July annual meeting. The Mentor, Ohio, maker of healthcare technologies is asking shareholders to approve a “nonbinding, advisory proposal” to endorse or not endorse its policies and procedures on executive pay. Such votes often are called “Say on […]
STERIS Corp. (NYSE: STE) is investing $11 million in an headquarters expansion to create an interactive showcase for its health technologies that it hopes will change the way it works with customers. The Mentor, Ohio maker of infection prevention, decontamination and health science technologies will use more than $5 million in city and state tax […]
Updated 3:09 p.m. Consumables. That’s one thing that helped STERIS Corp. (NYSE: STE) make up some of the revenue ground lost to troubles over the company’s System 1 sterilizer and other uncertainties in fiscal 2010. The Mentor, Ohio, healthcare technology maker continued its quest for operating efficiency in the year ended March 30, leading to […]